NUDT1, DCPS, NUDT5, EIF3D, NCBP2, CYFIP1, LSM1, GEMIN5, IFIT5, NCBP1, EIF4E, EIF4G3, LARP1, EIF4E3, CYFIP2, NCBP2L, and EIF4E1B expression levels were significantly different between the glioma group and normal group. This evidence concerns the gene NCBP2 and central nervous system cancer.